Education
About Us
Working with TipRanks
Follow Us
Nuo Therapeutics Inc (AURX)
:AURX
AURX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.76
Previous CloseN/A
Volume8.36K
Average Volume (3M)1.66K
Market Cap
$56.85M
Enterprise ValueN/A
Total Cash (Recent Filing)$636.93K
Total Debt (Recent Filing)$309.01K
Price to Earnings (P/E)―
Beta-0.16
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding46,598,404
10 Day Avg. Volume1,036
30 Day Avg. Volume1,658
Standard Deviation1348.25
R-Squared0.00180
Alpha199.67
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)48.70
Price to Cash Flow (P/CF)-29.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Nuo Therapeutics News
---
Ownership Overview
43.40% Insiders
―
Mutual Funds
― Other Institutional Investors
56.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AURX FAQ
What was Nuo Therapeutics Inc’s price range in the past 12 months?
Nuo Therapeutics Inc lowest stock price was $0.25 and its highest was $1.76 in the past 12 months.
What is Nuo Therapeutics Inc’s market cap?
Nuo Therapeutics Inc’s market cap is $56.85M.
When is Nuo Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nuo Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Nuo Therapeutics Inc overvalued?
According to Wall Street analysts Nuo Therapeutics Inc’s price is currently Overvalued.
Does Nuo Therapeutics Inc pay dividends?
Nuo Therapeutics Inc does not currently pay dividends.
What is Nuo Therapeutics Inc’s EPS estimate?
Nuo Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuo Therapeutics Inc have?
Nuo Therapeutics Inc has 46,598,404 shares outstanding.
What happened to Nuo Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nuo Therapeutics Inc?
Currently, no hedge funds are holding shares in AURX
---
Company Description
Nuo Therapeutics Inc
Nuo Therapeutics, Inc. engages in developing and marketing products for chronic wound care. It offers Aurix point of care technology for the safe and efficient separation of autologous blood to produce a platelet based therapy for the chronic wound care market. The company was founded on April 29, 1998 and is headquartered in Gaithersburg, MD.
---
Technical Analysis
---